The ECL Access to Medicines Task Force invites you to join a 1h30min webinar which will go through the 'What is a Fair Price' paper, reflecting on different pricing models for medicines, a new definition of what ECL believes to be a ‘fair price’ and a set of recommendations for decision-makers and the pharmaceutical industry.

Invited speakers (from the European Commission, European Parliament, EURORDIS, AIM, Danish Cancer Society, Roche & others) will reflect on the recommendations and state their priorities for the upcoming Pharmaceutical Strategy for Europe.